KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 72 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 1.04 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $765,000 | -49.9% | 85,768 | -25.6% | 0.00% | -50.0% |
| Q4 2015 | $1,528,000 | +9.4% | 115,273 | -13.1% | 0.00% | 0.0% |
| Q3 2015 | $1,397,000 | -63.0% | 132,621 | -4.4% | 0.00% | -55.6% |
| Q2 2015 | $3,775,000 | -5.7% | 138,706 | +6.1% | 0.01% | 0.0% |
| Q1 2015 | $4,002,000 | -43.5% | 130,760 | -30.9% | 0.01% | -50.0% |
| Q4 2014 | $7,083,000 | +138.1% | 189,258 | +122.3% | 0.02% | +157.1% |
| Q3 2014 | $2,975,000 | -29.0% | 85,143 | -5.5% | 0.01% | -36.4% |
| Q2 2014 | $4,193,000 | +85.1% | 90,077 | +22.8% | 0.01% | +83.3% |
| Q1 2014 | $2,265,000 | – | 73,329 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,200,396 | $30,084,000 | 1.72% |
| TFS CAPITAL LLC | 105,040 | $987,000 | 0.26% |
| Tekla Capital Management LLC | 500,324 | $4,703,000 | 0.20% |
| Piermont Capital Management Inc. | 51,080 | $480,000 | 0.11% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 55,793 | $524,000 | 0.09% |
| Candriam S.C.A. | 390,000 | $3,666,000 | 0.08% |
| Virtus ETF Advisers LLC | 27,446 | $258,000 | 0.08% |
| SECOR Capital Advisors, LP | 66,484 | $625,000 | 0.08% |
| Trexquant Investment LP | 29,007 | $273,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 32,196 | $303,000 | 0.04% |